Listeria monocytogenes infection in Crohn’s disease treated with adalimumab

• Royal Hobart Hospital, Hobart, TAS.

---

• 1. Schuchat A, Swaminathan B, Broome CV. Epidemiology of human listeriosis. Clin Microbiol Rev 1991; 4: 169-183.
• 2. Allerberger F, Wagner M. Listeriosis: a resurgent foodborne infection. Clin Microbiol Infect 2010; 16: 16-23.
• 3. Pamer EG. Immune responses to Listeria monocytogenes. Nat Rev Immunol 2004; 4: 812-823.
• 4. Anaissie E, Kontoyiannis DP, Kantarjian H, et al. Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone. Ann Intern Med 1992; 117: 466-469.
• 5. Wallis RS, Broder MS, Wong JY, et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004; 38: 1261-1265.
• 6. Dixon WG, Watson K, Lunt M, et al. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2006; 54: 2368-2376.
• 7. Murphy G, Schmidt-Martin D, Hynes BG, Harney S. Systemic listeriosis with adalimumab therapy. J Clin Rheumatol 2009; 15: 369-370.
• 8. Gil C, Legido J, Cuenca C, et al. [Meningitis due to Listeria monocytogenes during adalimumab therapy] [Spanish]. Gastroenterol Hepatol 2009; 32: 587-588.
• 9. Peña-Sagredo JL, Hernández MV, Fernandez-Llanio N, et al. Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience. Clin Exp Rheumatol 2008; 26: 854-859.
• 10. Hohmann EL, Kim J. Case records of the Massachusetts General Hospital. Case 8-2012. A 53-year-old man with Crohn's disease, diarrhea, fever, and bacteremia. N Engl J Med 2012; 366: 1039-1045.
• 11. Slifman NR, Gershon SK, Lee JH, et al. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 2003; 48: 319-324.
• 12. US Food and Drug Administration. FDA drug safety communication: drug labels for the tmor necrosis factor-alpha (TNFα) blockers now include warnings about infection with Legionella and Listeria bacteria. Silver Spring, MD: FDA, 2010. http://www.fda.gov/Drugs/DrugSafety/ucm270849.htm (accessed Feb 2012).
• 13. Antibiotic Expert Group. Therapeutic guidelines: antibiotic. Version 14. Melbourne: Therapeutic Guidelines Limited, 2010: 69-78.